| Literature DB >> 34043942 |
Ramon C Sun1, Lyndsay E A Young2, Ronald C Bruntz3, Kia H Markussen3, Zhengqiu Zhou3, Lindsey R Conroy4, Tara R Hawkinson5, Harrison A Clarke5, Alexandra E Stanback5, Jessica K A Macedo3, Shane Emanuelle3, M Kathryn Brewer6, Alberto L Rondon3, Annette Mestas3, William C Sanders3, Krishna K Mahalingan7, Buyun Tang7, Vimbai M Chikwana7, Dyann M Segvich7, Christopher J Contreras7, Elizabeth J Allenger8, Christine F Brainson9, Lance A Johnson8, Richard E Taylor10, Dustin D Armstrong11, Robert Shaffer12, Charles J Waechter3, Craig W Vander Kooi2, Anna A DePaoli-Roach7, Peter J Roach7, Thomas D Hurley7, Richard R Drake13, Matthew S Gentry14.
Abstract
Glycosylation defects are a hallmark of many nervous system diseases. However, the molecular and metabolic basis for this pathology is not fully understood. In this study, we found that N-linked protein glycosylation in the brain is metabolically channeled to glucosamine metabolism through glycogenolysis. We discovered that glucosamine is an abundant constituent of brain glycogen, which functions as a glucosamine reservoir for multiple glycoconjugates. We demonstrated the enzymatic incorporation of glucosamine into glycogen by glycogen synthase, and the release by glycogen phosphorylase by biochemical and structural methodologies, in primary astrocytes, and in vivo by isotopic tracing and mass spectrometry. Using two mouse models of glycogen storage diseases, we showed that disruption of brain glycogen metabolism causes global decreases in free pools of UDP-N-acetylglucosamine and N-linked protein glycosylation. These findings revealed fundamental biological roles of brain glycogen in protein glycosylation with direct relevance to multiple human diseases of the central nervous system.Entities:
Keywords: Lafora disease; MALDI imaging; N-linked glycosylation; antibody-enzyme therapy; brain metabolism; childhood dementia; glucosamine; glycogen metabolism; glycogen storage disease; polyglucosan body
Mesh:
Substances:
Year: 2021 PMID: 34043942 PMCID: PMC8266748 DOI: 10.1016/j.cmet.2021.05.003
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 31.373